Valuing a technology company for fundraising: The ten factors that set your number
How is a technology company valued for fundraising? Price Bailey's Chand Chudasama sets out the ten factors investors weigh before backing your raise.
Luxury Goods
With a value of over €280 billion, the global personal luxury goods market has been on the increase for many years.
No matter your goals, we can help
An industry that is synonymous with GDP, luxury goods businesses will often see demand climb in times of economic stability and plummet during unfavourable economic climates.
Given the current economic outlook, now is as important a time as any for luxury goods companies to be prepared and address rapidly evolving challenges, and our team of expert accountants and financial, tax, and strategic advisers can help you reach your goals
Services tailored to you
Whether you would like advice on creating and implementing a strategy that will increase your competitiveness, boost growth, and increase profits, or a financial model to stress test different scenarios, we can support you.
We can provide:
- a range of fully inclusive company secretarial services
- a partly or fully outsourced credit control service tailored to your needs
- a fully outsourced payroll function, including administration and pension responsibilities
- audit and accounting services
- tax and group structure solutions
- advice on mergers and acquisitions
- financial modelling
- guidance on different types of funding including, private equity funding and lending
- management buy-outs and buy-ins
- creating a strategic plan
Supporting the long-term success of your business
To support luxury goods companies, we have crafted our service offering to make sure that at whichever stage of your business lifecycle you find yourself, we have a service offering that will support you.
Read our insights here
CQC’s new primary care framework: What GP practices should do now
CQC is retiring its single assessment framework for a primary care specific model from late 2026. Here's what's changing for GP practices, and what to do now.
Price Bailey supports NRG Therapeutics’ transition to clinical-stage biotech
How Price Bailey supports NRG Therapeutics with investor-led audit and governance advice as it transitions from discovery-stage research to clinical development...
Company valuation webinar series
Stay up-to-date with the data and stories emerging from UK valuations.